Crystal Coma is a moderately potent indica cannabis strain that has gained popularity among Canadian cannabis consumers for its distinctive profile. With 19% THC and minimal CBD at 0.1%, Crystal Coma delivers deep physical relaxation and full-body calm that makes it well-suited for unwinding after a long day, managing pain, and promoting restful sleep. Users commonly report feeling relaxed, happy, and euphoric after consuming this strain.
While the precise breeding history of Crystal Coma is not widely documented, the strain has established itself in the Canadian cannabis market through its consistent effects and distinctive character. The indica profile suggests genetics that lean toward traditional indica lineages, producing a reliable experience that has earned a loyal following among cannabis consumers across Canada.
Crystal Coma produces dense, tightly packed buds with a compact structure typical of quality indica genetics. The flowers are rich green colouration with a generous coating of frosty trichomes that signal the strain's moderate potency. The aroma greets the nose with rich, earthy soil as the dominant note, layered with fresh pine forest and warm, woody notes. When consumed, the flavour faithfully delivers on the aroma's promise — rich, earthy soil leads the inhale with fresh pine forest emerging on the exhale. The smoke is smooth and flavourful, making Crystal Coma an enjoyable choice for consumers who appreciate a well-defined taste profile.
Crystal Coma delivers deep physical relaxation and full-body calm that unfolds in a satisfying progression. The initial onset brings a soothing wave of relaxation that melts away tension, followed closely by an uplifting sense of happiness and contentment. As the experience develops, users also notice a blissful euphoria that elevates mood and outlook. A gentle drowsiness that naturally guides users toward restful sleep rounds out the experience, creating a well-layered effect profile that keeps Crystal Coma interesting from start to finish. The moderate THC content of 19% means the effects are substantial without being overwhelming for most consumers. Crystal Coma is best enjoyed during evening and nighttime hours when its effects can be fully appreciated.
Crystal Coma's therapeutic potential makes it a valuable option for medical cannabis patients in Canada. The strain's indica profile is particularly well-suited for addressing chronic pain, insomnia, muscle spasms, anxiety, and appetite stimulation. The deep physical relaxation can help manage chronic pain conditions including arthritis, back pain, and migraines. The sedative qualities make it effective for patients struggling with insomnia and sleep disorders, promoting natural sleep onset without pharmaceutical dependency. Appetite stimulation is another common benefit, helping patients dealing with appetite loss from medical treatments or eating disorders.
Crystal Coma's terpene profile is led by Myrcene, Caryophyllene, and Limonene, creating a distinctive aromatic and therapeutic fingerprint. Myrcene contributes earthy and musky notes while promoting relaxation and enhancing the sedative qualities of THC. Myrcene is the most common terpene in cannabis and is also found in mangoes, hops, and lemongrass. Caryophyllene contributes spicy and peppery notes while providing anti-inflammatory and analgesic properties by interacting directly with the CB2 receptor. Caryophyllene is unique among terpenes as the only one known to directly bind to cannabinoid receptors, and is also found in black pepper and cloves. Limonene contributes bright citrus notes while elevating mood and providing stress relief. Limonene is also abundant in citrus fruit peels and has been studied for its potential anti-anxiety and antidepressant properties. Together, these terpenes work synergistically through the entourage effect, enhancing the overall therapeutic impact beyond what THC and CBD alone would provide.
For the best experience with Crystal Coma, consume during evening and nighttime hours. Vaporizing at temperatures between 190-205°C will fully activate the sedative terpenes and deliver maximum relaxation. Have comfortable seating and snacks prepared, as motivation to move may decrease as the effects deepen. Crystal Coma pairs well with calming activities like reading, listening to music, or watching films.
Crystal Coma displays a compact, bushy structure with broad leaves that makes it well-suited for indoor growing environments with limited vertical space. The compact plants typically finish flowering in 7 to 9 weeks and produce dense, resinous buds. The strain's indica heritage contributes natural resilience to common pests and environmental stress, making it a relatively forgiving choice for growers at various experience levels.
No reviews yet. Be the first to review Crystal Coma!
